Who is under a slight risk for severe storms on 1st day of summer?
Published Sat, 22 Feb 2025 03:49:58 GMT
Bulgaria offers EU two candidates for vacant commissioner post
Published Sat, 22 Feb 2025 03:49:58 GMT
PMQs scorecard: Starmer attacks Sunak over the ‘Tory mortgage penalty’
Published Sat, 22 Feb 2025 03:49:58 GMT
Column: Could Chicago Cubs ace Marcus Stroman start for NL in the All-Star Game?
Published Sat, 22 Feb 2025 03:49:58 GMT
Underwater noises heard in desperate search for submersible missing with 5 aboard near Titanic
Published Sat, 22 Feb 2025 03:49:58 GMT
Indian Prime Minister Modi showcases yoga and his country’s cultural diplomacy on the UN lawn
Published Sat, 22 Feb 2025 03:49:58 GMT
Israeli settlers torch Palestinian homes, cars to avenge deadly shooting
Published Sat, 22 Feb 2025 03:49:58 GMT
What was Hungary’s role in freeing Ukrainian POWs from Russia? The European Commission wants to know
Published Sat, 22 Feb 2025 03:49:58 GMT
Japan’s Kishida says he will attend NATO leaders’ summit, stresses need for dialogue with China
Published Sat, 22 Feb 2025 03:49:58 GMT
Delaware Congresswoman Lisa Blunt Rochester announces bid for US Senate
Published Sat, 22 Feb 2025 03:49:58 GMT
Latest news
- RPM International, Acuity Brands rise; Cal-Maine, Helen of Troy fall, Wednesday, 10/4/2023
- Kenyan opposition lawmakers say the Haiti peacekeeping mission must be approved by parliament
- Tennis player apologizes for hitting a chair umpire with ball in Shanghai Masters qualifying
- Jannik Sinner wins China Open. Iga Swiatek advances to quarterfinals
- Pakistani army says 2 people were killed when a Taliban guard opened fire at a border crossing
- Meet this year’s MacArthur ‘genius grant’ recipients, including a hula master and the poet laureate
- A man charged with voter fraud in Florida blames rivalry between Trump and DeSantis supporters
- Rudy Giuliani: ‘I have never had an alcohol problem’
- Scalise and Jordan launch bids for House speaker after McCarthy ouster
- Moderna’s flu-Covid combo vaccine elicits ‘strong’ immune response in Phase 1/2 study, company says